Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
HRL enters mid-October with short sellers stepping up the pressure, the Street trimming its price targets, and the stock down another 3.4% on the week to $19.21, a level that puts Hormel well below where even the more cautious analysts thought it would be trading.
The most material change since last week's note is the acceleration in short interest. Shares short have climbed to 4.8% of the free float, up 25% on the week and 52% over the past month. That is a genuine shift in conviction: a month ago, short interest was running at roughly 3.1% of float, a level that barely warranted attention. At 4.8%, and with the direction firmly upward, the bear camp is growing. The short score confirms the move, jumping from 41 to 47 over the past week, its highest reading in the 10-day history available. Despite this buildup, the borrow market offers no friction. Cost to borrow has edged up to 0.50% from 0.41% last week, still firmly in "low" territory, and availability is wide at 334%, meaning there are more than three shares available to lend for every share already borrowed. Bears are not crowded out.
Options positioning runs counter to the short interest signal and tells a more relaxed story. The put/call ratio has dropped to 0.46, nearly one and a half standard deviations below its 20-day average of 0.54, and sits closer to the 52-week low of 0.30 than the high of 0.67. Call interest is running above put interest, which is unusual for a stock in a sustained downtrend. That divergence between rising short interest and relatively call-heavy options flow is worth watching: either the options market is behind the curve, or the short-interest build is hedging activity rather than pure directional conviction.
The Street has moved further in the wrong direction for bulls this week. Barclays kept its Overweight rating on Wednesday but cut its target from $30 to $28, citing continuing fundamental pressure. That follows BNP Paribas lowering its target from $26 to $23 last week, the second cut from that firm in two months. The consensus target now averages $25.31, implying 32% upside from the current price, though the trend in that figure is downward rather than supportive. The valuation multiples reflect the compression: the P/E has fallen to 12.4x, down from 13.7x over the past 30 days, and price-to-book has dropped to 1.35x. The EV/EBITDA of 9.1x is edging lower but does not yet screen as distressed for a packaged food name. The one factor score that stands out is dividend, ranked in the 98th percentile, a function of a stock price that has fallen faster than the payout. The bull case centres on six consecutive quarters of organic sales growth and a foodservice segment with genuine share gains. The bear case, which the market appears to be running with, focuses on retail volume declines, pork processing margin compression, and tariff exposure across a commodity-intensive portfolio.
The institutional picture is stable but dominated by one factor: the Hormel Foundation holds 46.6% of shares outstanding and has not moved. That degree of anchor ownership means the free float is considerably smaller than the share count implies, and it is this smaller float against which the short interest percentage is calculated. Dimensional Fund Advisors added 2.5 million shares as of September 30, the largest institutional move in the period, while most other major holders made incremental additions. Director William Newlands' open-market purchase of 10,000 shares at $20.10 on October 5, highlighted in last week's note, remains the only discretionary insider buy in the recent record. The stock has since slipped further below that entry price.
Hormel's next earnings print is scheduled for December 3. The August result produced a one-day move of minus 9%, with further weakness extending through the following five sessions. With short interest now at a fresh high for the period observed and the stock testing levels not seen in years, the December print will be the next hard test of whether the recovery story has any traction.
See the live data behind this article on ORTEX.
Open HRL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
